Sex differences in circulating endocannabinoid concentrations during adolescence: Associations with pubertal development
Julia M. Evanski, Tristin Smith, Adriene M. Beltz, Esmeralda Hidalgo-Lopez, Christel M. Portengen, Andrew Schrepf, Steven E. Harte, Chelsea M. Kaplan Neuropsychopharmacology
· Springer Nature
· 2026-10-15
· DOI: 10.1038/s41386-026-02574-0
Abstract
Neuropsychopharmacology, Published online: 15 October 2026; doi:10.1038/s41386-026-02574-0 Sex differences in circulating endocannabinoid concentrations during adolescence: Associations with pubertal development
Julia M. Evanski, Tristin Smith, Adriene M. Beltz, Esmeralda Hidalgo-Lopez, Christel M. Portengen, Andrew Schrepf et al. Sex differences in circulating endocannabinoid concentrations during adolescence: Associations with pubertal development. // Neuropsychopharmacology. – 2026. – DOI: 10.1038/s41386-026-02574-0. – URL: https://www.nature.com/articles/s41386-026-02574-0
Julia M. Evanski, Tristin Smith, Adriene M. Beltz, Esmeralda Hidalgo-Lopez, Christel M. Portengen, Andrew Schrepf, Steven E. Harte, & Chelsea M. Kaplan (2026). Sex differences in circulating endocannabinoid concentrations during adolescence: Associations with pubertal development. Neuropsychopharmacology. https://doi.org/10.1038/s41386-026-02574-0
Julia M. Evanski, et al. “Sex differences in circulating endocannabinoid concentrations during adolescence: Associations with pubertal development.” Neuropsychopharmacology, 2026. doi:10.1038/s41386-026-02574-0.
@article{Evanski2026,
title = {Sex differences in circulating endocannabinoid concentrations during adolescence: Associations with pubertal development},
author = {Evanski, Julia M. and Smith, Tristin and Beltz, Adriene M. and Hidalgo-Lopez, Esmeralda and Portengen, Christel M. and Schrepf, Andrew and Harte, Steven E. and Kaplan, Chelsea M.},
journal = {Neuropsychopharmacology},
year = {2026},
doi = {10.1038/s41386-026-02574-0},
url = {https://www.nature.com/articles/s41386-026-02574-0}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...